Dr Yiping Chen
Senior Research Fellow
Yiping Chen is a senior research fellow at the CTSU, University of Oxford. She qualified in clinical medicine in 1985 at Shanghai Medical University (now Fudan University) and then worked as junior neurologist in University affiliated teaching hospital, Hua-shan hospital in Shanghai. In 1988 she was awarded Sino-British Friendship Scholarship to study in the UK and gained her PhD at the University of Oxford in 1993.
She joined CTSU in 1998 and has worked as study coordinator and senior research fellow in several CTSU-led large clinical trials such as COMMIT/CCS2, SHARP, HPS2-THRIVE, REVEAL. During 2006-2016 she also plays a leading role in running Oxford-China Fellowship programmes which provides residence training in epidemiology, medical statistics and clinical trials methodology for the clinical doctors, public health workers from China.
She is currently leading a multi-disciplinary team in the China Kadoorie Biobank (CKB) of 0.5 million people, responsible for developing strategies and procedures related to validation of electronically reported clinical events and for conducting disease validation and adjudication in collaboration with clinical specialists in China for CKB. Her main research interests are in the fields of clinical epidemiology of cardiovascular diseases, major depression, and sleeping disorders
Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations.
Zhu X. et al, (2023), BMC Med, 21
Long-term exposure to fine particulate matter and incidence of esophageal cancer: a prospective study of 0.5 million Chinese adults.
Sun D. et al, (2023), Gastroenterology
Association of dietary patterns, circulating lipid profile, and risk of obesity.
Pan L. et al, (2023), Obesity (Silver Spring)
Long-term exposure to ambient PM2·5, active commuting, and farming activity and cardiovascular disease risk in adults in China: a prospective cohort study.
Sun D. et al, (2023), Lancet Planet Health, 7, e304 - e312
Healthy lifestyle, DNA methylation age acceleration, and incident risk of coronary heart disease.
Si J. et al, (2023), Clin Epigenetics, 15